Global Information
회사소개 | 문의 | 비교리스트

세계의 통증 관리 패치 시장

Global Market for Pain Management Patches

리서치사 BCC Research
발행일 2020년 06월 상품 코드 943530
페이지 정보 영문 136 Pages
가격
US $ 5,500 ₩ 6,499,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 1회이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,600 ₩ 7,799,000 PDF by E-mail (2-5 Users) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 5회까지이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,920 ₩ 9,359,000 PDF by E-mail (Site License) help
동일 사업장 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,504 ₩ 11,231,000 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 통증 관리 패치 시장 Global Market for Pain Management Patches
발행일 : 2020년 06월 페이지 정보 : 영문 136 Pages

세계의 통증 관리 패치 시장은 2018년 42억 달러에서 2023년까지 53억 달러에 달하고, 2018-2023년간 연평균 복합 성장률(CAGR) 4.5%를 나타낼 전망입니다. 펜타닐 패치 시장은 2018년 14억 달러에서 2023년까지 17억 달러에 달하고, 2023년까지 CAGR 3.2%를 나타낼 전망입니다. 리도카인 시장은 2018년 9억 8,450만 달러에서 2023년까지 13억 달러에 달하고, 2023년까지 CAGR 5.6%를 나타낼 전망입니다.

세계의 통증 관리 패치(Pain Management Patches) 시장에 대해 조사 분석했으며, 시장 개요, 시장 분석, 경쟁 상황, 주요 기업 등에 대해 체계적인 정보를 전해드립니다.

목차

제1장 서론

제2장 요약 및 하이라이트

제3장 시장과 기술의 배경

  • 통증 관리 패치
  • 병태생리와 병인
  • 국소 제제 및 국소 전달 시스템
  • 만성 통증 유병률
  • 통증 관리 패치 동향

제4장 시장 역학

  • 시장 성장 촉진요인
  • 급성/만성 통증 발생률 증가
  • 노인 인구 증가와 관련된 정형외과
  • 경피 패치 설계 개발
  • 새로운 통증 관리용 비오피오이드 약물
  • 시장 성장 억제요인
  • 통증 관리 패치의 부작용
  • 의약품 개발의 높은 비용과 제조업체에 대한 가격 압력
  • 시장 기회
  • 새로운 통증 관리용 패치 출시
  • 경피 패치의 치료 유효성분 증가

제5장 시장 분석 : 사용하는 의약품별

  • 서론
  • Fentanyl
  • Buprenorphine
  • Lidocaine
  • Diclofenac
  • Ketoprofen
  • Capsaicin
  • Methyl Salicylate
  • Menthol
  • 기타

제6장 시장 분석 : 주요 부문별

  • 서론
  • Over the Counter (OTC)
  • 처방

제7장 시장 분석 : 통증 카테고리별

  • 서론
  • 급성 통증
  • 만성 통증

제8장 시장 분석 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제9장 규제 환경

  • 미국의 규제
  • 신약 승인
  • 1997년 FDA 현대화법
  • Fast Track 상황
  • 특별심사(SPA)
  • 메디케이드와 메디케어
  • 새로운 통증 관리 패치 임상 평가의 원칙
  • 유럽의 규제
  • 가격과 상환
  • 일본의 규제
  • 중국의 규제
  • 인도의 규제

제10장 경쟁 상황

  • 세계의 기업 점유율 분석
  • 인수합병(M&A)
  • 계약, 협업, 제휴
  • 제네릭 통증 관리 패치가 시장에 미치는 영향

제11장 기업 개요

  • ENDO PHARMACEUTICALS INC.
  • GLAXOSMITHKLINE PLC
  • GRUNENTHAL
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • ICURE PHARMA INC.
  • JOHNSON & JOHNSON
  • MYLAN NV
  • NOVARTIS AG
  • PFIZER INC.
  • SANOFI
  • SPARSHA PHARMA INTERNATIONAL PVT. LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.

제12장 부록 : 약어

LSH 20.07.13

List of Tables

  • Summary Table: Global Market for Pain Management Patches, by the Drug Used, Through 2023
    • Table 1: Classification of Pain Management Patches
    • Table 2: Global Market for Pain Management Patches, by the Drug Used, Through 2023
    • Table 3: Global Market for Fentanyl Pain Management Patches, by Region, Through 2023
    • Table 4: Global Market for Buprenorphine Pain Management Patches, by Region, Through 2023
    • Table 5: Global Market for Lidocaine Pain Management Patches, by Region, Through 2023
    • Table 6: Global Market for Diclofenac Pain Management Patches, by Region, Through 2023
    • Table 7: Global Market for Ketoprofen Pain Management Patches, by Region, Through 2023
    • Table 8: Global Market for Capsaicin Pain Management Patches, by Region, Through 2023
    • Table 9: Global Market for Methyl Salicylate Pain Management Patches, by Region, Through 2023
    • Table 10: Global Market for Menthol Pain Management Patches, by Region, Through 2023
    • Table 11: Global Market for Other Types of Pain Management Patches, by Region, Through 2023
    • Table 12: Products Categorized into OTC and Prescription Drugs
    • Table 13: Global Market for Over-the-Counter Pain Management Patches, by Region, Through 2023
    • Table 14: Global Market for Prescription Pain Management Patches, by Region, Through 2023
    • Table 15: Global Market for Pain Management Patches for Acute Pain, by Region, Through 2023
    • Table 16: Global Market for Pain Management Patches for Chronic Pain, by Region, Through 2023
    • Table 17: Global Market for Pain Management Patches, by Region, Through 2023
    • Table 18: North American Market for Pain Management Patches, by the Drug Used, Through 2023
    • Table 19: North American Market for Pain Management Patches, by Major Segment, Through 2023
    • Table 20: North American Market for Pain Management Patches, by Category of Pain, Through 2023
    • Table 21: North American Market for Pain Management Patches, by Country, Through 2023
    • Table 22: European Market for Pain Management Patches, by the Drug Used, Through 2023
    • Table 23: European Market for Pain Management Patches, by Major Segment, Through 2023
    • Table 24: European Market for Pain Management Patches, by Category of Pain, Through 2023
    • Table 25: European Market for Pain Management Patches, by Country, Through 2023
    • Table 26: Asia-Pacific Market for Pain Management Patches, by the Drug Used, Through 2023
    • Table 27: Asia-Pacific Market for Pain Management Patches, by Major Segment, Through 2023
    • Table 28: Asia-Pacific Market for Pain Management Patches, by Category of Pain, Through 2023
    • Table 29: Asia-Pacific Market for Pain Management Patches, by Country, Through 2023
    • Table 30: Rest of the World Market for Pain Management Patches, by the Drug Used, Through 2023
    • Table 31: Rest of the World Market for Pain Management Patches, by Major Segment, Through 2023
    • Table 32: Rest of the World Market for Pain Management Patches, by Category of Pain, Through 2023
    • Table 33: Endo Pharmaceuticals Inc.: Pain Management Patches Product Portfolio
    • Table 34: GlaxoSmithKline PLC: Pain Management Patches Product Portfolio
    • Table 35: Grunenthal: Pain Management Patches Product Portfolio
    • Table 36: Hisamitsu Pharmaceutical Co. Inc.: Pain Management Patches Product Portfolio
    • Table 37: ICURE Pharma Inc.: Pain Management Patches Product Portfolio
    • Table 38: Johnson & Johnson: Pain Management Patches Product Portfolio
    • Table 39: Mylan N.V.: Pain Management Patches Product Portfolio
    • Table 40: Novartis AG: Pain Management Patches Product Portfolio
    • Table 41: Pfizer Inc.: Pain Management Patches Product Portfolio
    • Table 42: Sanofi: Pain Management Patches Product Portfolio
    • Table 43: Sparsha Pharma International Pvt. Ltd.: Pain Management Patches Product Portfolio
    • Table 44: Teva Pharmaceutical Industries Ltd.: Pain Management Patches Product Portfolio
    • Table 45: Acronyms Used in This Report

List of Figures

  • Summary Figure: Global Market Shares of Pain Management Patches, by the Drug Used, 2017
    • Figure 1: Prevalence of Pain at Different Sites of the Body, 2014
    • Figure 2: Prevalence Rates of Chronic Pain in Different Age Groups, 2015 and 2016
    • Figure 3: Identified Non-opioid Drug Distribution, by Indication, 2017
    • Figure 4: Global Market Shares of Pain Management Patches, by the Drug Used, 2017
    • Figure 5: Global Market for Fentanyl Pain Management Patches, 2017-2023
    • Figure 6: Global Market for Fentanyl Pain Management Patches, by Region, 2017-2023
    • Figure 7: Global Market for Buprenorphine Pain Management Patches, 2017-2023
    • Figure 8: Global Market for Buprenorphine Pain Management Patches, by Region, 2017-2023
    • Figure 9: Global Market for Lidocaine Pain Management Patches, 2017-2023
    • Figure 10: Global Market for Lidocaine Pain Management Patches, by Region, 2017-2023
    • Figure 11: Global Market for Diclofenac Pain Management Patches, 2017-2023
    • Figure 12: Global Market for Diclofenac Pain Management Patches, by Region, 2017-2023
    • Figure 13: Global Market for Ketoprofen Pain Management Patches, 2017-2023
    • Figure 14: Global Market for Ketoprofen Pain Management Patches, by Region, 2017-2023
    • Figure 15: Global Market for Capsaicin Pain Management Patches, 2017-2023
    • Figure 16: Global Market for Capsaicin Pain Management Patches, by Region, 2017-2023
    • Figure 17: Global Market for Methyl Salicylate Pain Management Patches, 2017-2023
    • Figure 18: Global Market for Methyl Salicylate Pain Management Patches, by Region, 2017-2023
    • Figure 19: Global Market for Menthol Pain Management Patches, 2017-2023
    • Figure 20: Global Market for Menthol Pain Management Patches, by Region, 2017-2023
    • Figure 21: Global Market for Other Types of Pain Management Patches, 2017-2023
    • Figure 22: Global Market for Other Types of Pain Management Patches, by Region, 2017-2023
    • Figure 23: Global Market for Over-the-Counter Pain Management Patches, 2017-2023
    • Figure 24: Global Market for Over-the-Counter Pain Management Patches, by Region, 2017-2023
    • Figure 25: Global Market for Prescription Pain Management Patches, 2017-2023
    • Figure 26: Global Market for Prescription Pain Management Patches, by Region, 2017-2023
    • Figure 27: Global Market for Pain Management Patches for Acute Pain, 2017-2023
    • Figure 28: Global Market for Pain Management Patches for Acute Pain, by Region, 2017-2023
    • Figure 29: Global Market for Pain Management Patches for Chronic Pain, 2017-2023
    • Figure 30: Global Market for Pain Management Patches for Chronic Pain, by Region, 2017-2023
    • Figure 31: Global Market Shares of Pain Management Patches, by Region, 2017
    • Figure 32: North American Market Shares of Pain Management Patches, by the Drug Used, 2017
    • Figure 33: North American Market Shares of Pain Management Patches, by Major Segment, 2017
    • Figure 34: North American Market Shares of Pain Management Patches, by Category of Pain, 2017
    • Figure 35: North American Market Shares of Pain Management Patches, by Country, 2017
    • Figure 36: U.S. Market for Pain Management Patches, 2017-2023
    • Figure 37: Canadian Market for Pain Management Patches, 2017-2023
    • Figure 38: Canadian Cancer Statistics, 2019
    • Figure 39: European Market Shares of Pain Management Patches, by the Drug Used, 2017
    • Figure 40: European Market Shares of Pain Management Patches, by Major Segment, 2017
    • Figure 41: European Market Shares of Pain Management Patches, by Category of Pain, 2017
    • Figure 42: European Market Shares of Pain Management Patches, by Country, 2017
    • Figure 43: German Market for Pain Management Patches, 2017-2023
    • Figure 44: French Market for Pain Management Patches, 2017-2023
    • Figure 45: U.K. Market for Pain Management Patches, 2017-2023
    • Figure 46: Italian Market for Pain Management Patches, 2017-2023
    • Figure 47: Spanish Market for Pain Management Patches, 2017-2023
    • Figure 48: Rest of European Market for Pain Management Patches, 2017-2023
    • Figure 49: Asia-Pacific Market Shares of Pain Management Patches, by the Drug Used, 2017
    • Figure 50: Asia-Pacific Market Shares of Pain Management Patches, by Major Segment, 2017
    • Figure 51: Asia-Pacific Market Shares of Pain Management Patches, by Category of Pain, 2017
    • Figure 52: Asia-Pacific Market Shares of Pain Management Patches, by Country, 2017
    • Figure 53: Japanese Market for Pain Management Patches, 2017-2023
    • Figure 54: Chinese Market for Pain Management Patches, 2017-2023
    • Figure 55: Indian Market for Pain Management Patches, 2017-2023
    • Figure 56: Australian and New Zealand Market for Pain Management Patches, 2017-2023
    • Figure 57: Rest of Asia-Pacific Market for Pain Management Patches, 2017-2023
    • Figure 58: Rest of the World Market for Pain Management Patches, 2017-2023
    • Figure 59: Rest of the World Market Shares of Pain Management Patches, by the Drug Used, 2017
    • Figure 60: Rest of the World Market Shares of Pain Management Patches, by Major Segment, 2017
    • Figure 61: Rest of the World Market Shares of Pain Management Patches, by Category of Pain, 2017
    • Figure 62: China SFDA Drug Regulatory Approval Process
    • Figure 63: Global Market Shares of Pain Management Patches, by Company, 2017
    • Figure 64: Endo Pharmaceuticals Inc.: Annual Revenue, 2016-2019
    • Figure 65: Endo Pharmaceuticals Inc.: Revenue Shares, by Established Product, 2019
    • Figure 66: GlaxoSmithKline PLC: Annual Revenue, 2016-2019
    • Figure 67: GlaxoSmithKline PLC: Revenue Shares, by Consumer Healthcare, 2019
    • Figure 68: Hisamitsu Pharmaceutical Co. Inc.: Pharmaceutical Segment Annual Revenue, 2016-2019
    • Figure 69: Hisamitsu Pharmaceutical Co. Inc.: Revenue Shares, by Region, 2019
    • Figure 70: Johnson & Johnson: Annual Revenue, 2016-2019
    • Figure 71: Johnson & Johnson: Revenue Shares, by Region, 2019
    • Figure 72: Johnson & Johnson: Revenue Shares, by Business Unit, 2019
    • Figure 73: Mylan N.V.:Annual Revenue, 2016-2019
    • Figure 74: Mylan N.V.: Revenue Shares, by Region, 2019
    • Figure 75: Mylan N.V.: Revenue Shares, by Business Unit, 2019
    • Figure 76: Novartis AG: Annual Revenue, 2015-2019
    • Figure 77: Novartis AG: Revenue Shares, by Region, 2019
    • Figure 78: Novartis AG: Revenue Shares, by Business Segment, 2019
    • Figure 79: Pfizer Inc.: Annual Revenue, 2016-2019
    • Figure 80: Pfizer Inc.: Revenue Shares, by Region, 2019
    • Figure 81: Pfizer Inc.: Revenue Shares, by Business Segment, 2019
    • Figure 82: Sanofi.: Annual Revenue, 2016-2019
    • Figure 83: Sanofi: Revenue Shares, by Region, 2019
    • Figure 84: Sanofi: Revenue Shares, by Segment, 2019
    • Figure 85: Teva Pharmaceutical Industries Ltd.: Generic Segment Annual Revenue, 2016-2019
    • Figure 86: Teva Pharmaceutical Industries Ltd.: Revenue Shares, by Region, 2019

Highlights:

The global market for pain management patches should grow from $4.2 billion in 2018 to $5.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.5% for the period of 2018-2023.

Fentanyl patches market should grow from $1.4 billion in 2018 to $1.7 billion by 2023 at a CAGR of 3.2% through 2023.

Lidocaine market should grow from $984.5 million in 2018 to $1.3 billion by 2023 at a CAGR of 5.6% through 2023.

Report Scope:

The current report offers a detailed picture of the pain relief patch market. Opioid and NSAID pain management patches have been analyzed in the report, and patch regulations and demand for addressing different types of pain have been included in the scope of the study. The report excludes drugs used in the treatment of hormonal pain. The market size includes both branded and generic drugs.

The report highlights the current and future market potential of pain management patches and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2023, as well as market shares for key market players.

The report details market shares of pain management patches based on drug, major segment, application and geography.

Based on drug, the market is segmented into fentanyl patches, buprenorphine, lidocaine, diclofenac, ketoprofen, capsaicin, methyl salicylate, menthol and others (glycol salicylate, tocopherol acetate, camphor, etc.).

Based on major segment, the market is segmented into over the counter (OTC) and prescription.

Based on category of pain, the market is segmented into acute pain and chronic pain.

By geography, the market has been segmented into North America, Europe, Asia-Pacific and Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Spain, Italy, Japan, China, Australia, New Zealand and India are covered in regional segments. For market estimates, data has been provided for the year 2017 as the base year, with forecasts for 2018 through 2023. Estimated values used are based on drug manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

  • 31 data tables and 15 additional tables
  • An overview of the global market for pain management drugs used in the form of patches for immediate relief from any type of pain
  • Analyses of global market trends, with market data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Assessment of current market size, market forecast, and main driving forces for the pain relief patches market
  • Briefing about antihypertensive drugs, their pathophysiology and pathogenesis and major adverse effects of various antihypertensive drugs
  • Information on significant products, issues and trends, market influences, regulatory issues and other information affecting the pain relief patches market
  • Profile description of major market players including Endo Pharmaceuticals Inc., GlaxoSmithKline PLC, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., and Sanofi

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Pain Management Patches
  • Pathophysiology and Pathogenesis
  • Topical Preparations and Topical Delivery Systems
  • Prevalence of Chronic Pain
  • Trends in Pain Management Patches

Chapter 4: Market Dynamics

  • Market Drivers
  • Increasing Incidence of Acute and Chronic Pain
  • Rise in Geriatric Population and Related Orthopedic Surgery
  • Developments in Transdermal Patch Design
  • Emerging Non-opioid Drugs for Pain Management
  • Market Restraints
  • Side Effects of Pain Management Patches
  • High Cost of Drug Development and Pricing Pressures on Manufacturers
  • Market Opportunities
  • Launch of New Patches for Pain Management
  • Rise in Number of Therapeutically Active Substances for Transdermal Patches

Chapter 5: Market Breakdown by the Drug Used

  • Introduction
  • Fentanyl
  • Market Size and Forecast
  • Market Analysis
  • Buprenorphine
  • Market Size and Forecast
  • Market Analysis
  • Lidocaine
  • Market Size and Forecast
  • Market Analysis
  • Diclofenac
  • Market Size and Forecast
  • Market Analysis
  • Ketoprofen
  • Market Size and Forecast
  • Market Analysis
  • Capsaicin
  • Market Size and Forecast
  • Market Analysis
  • Methyl Salicylate
  • Market Size and Forecast
  • Market Analysis
  • Menthol
  • Market Size and Forecast
  • Market Analysis
  • Others
  • Market Size and Forecast
  • Market Analysis

Chapter 6: Market Breakdown by Major Segment

  • Introduction
  • Over the Counter (OTC)
  • Market Size and Forecast
  • Prescription
  • Market Size and Forecast

Chapter 7: Market Breakdown by Category of Pain

  • Introduction
  • Acute Pain
  • Market Size and Forecast
  • Market Analysis
  • Chronic Pain
  • Market Size and Forecast
  • Market Analysis

Chapter 8: Market Breakdown by Region

  • Introduction
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia and New Zealand
  • Rest of Asia-Pacific
  • Rest of World
  • Market Size and Forecast
  • Market Analysis

Chapter 9: Regulatory Environment

  • Regulations in the U.S.
  • New Drug Approvals
  • FDA Modernization Act of 1997
  • Fast Track Status
  • Special Protocol Assessments
  • Medicaid and Medicare
  • Principles for Clinical Evaluation of New Pain Management Patches
  • Regulations in Europe
  • Pricing and Reimbursement
  • Regulations in Japan
  • Regulations in China
  • Regulations in India

Chapter 10: Competitive Landscape

  • Global Analysis of Company Shares
  • Mergers and Acquisitions
  • Agreements, Collaborations and Partnerships
  • Market Impact of Generic Pain Management Patches

Chapter 11: Company Profiles

  • ENDO PHARMACEUTICALS INC.
  • GLAXOSMITHKLINE PLC
  • GRUNENTHAL
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • ICURE PHARMA INC.
  • JOHNSON & JOHNSON
  • MYLAN N.V.
  • NOVARTIS AG
  • PFIZER INC.
  • SANOFI
  • SPARSHA PHARMA INTERNATIONAL PVT. LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.

Chapter 12: Appendix: Acronyms

Back to Top
전화 문의
F A Q